|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/437 | |
| C07D 213/74 | |||
| C07D 498/08 | |||
| C07D 405/04 | |||
| C07D 413/04 | |||
| C07D 401/04 | |||
| A61P 7/00 | |||
| C07D 491/107 | |||
| A61P 43/00 | |||
| A61P 3/00 |
| (11) | Number of the document | 2968299 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14769616.5 |
| Date of filing the European patent application | 2014-03-10 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/022736 |
| Date | 2014-03-10 |
| (87) | Number | WO 2014/150258 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201313815874 | 2013-03-15 | US | |
| 201361905802 P | 2013-11-18 | US |
| (72) |
LI, Zhe, US
XU, Qing, US
METCALF, Brian W., US
GWALTNEY, II, Stephen L., US
HARRIS, Jason R., US
YEE, Calvin W., US
|
| (73) |
Global Blood Therapeutics, Inc.,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (54) | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN |
| COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN |